Loading live market data…

Axsome Therapeutics, Inc.

NASDAQ:AXSM

$235.26 USD

$6.98 (3.06%)

Volume
482.76K
Average Volume
923.51K
Market Capitalization
$12.11B
P/E Ratio
-63.07
Dividend Yield
0.00%
Price Target
$259.50
Year High
$260.19
Year Low
$96.09
Day High
—
Day Low
—
Payout Ratio
$0.00
Current Ratio
$1.39

AXSM Estimated and Actual Revenue by Quarter

AXSM Estimated and Actual EPS by Quarter

AXSM Analyst Forecasts

Quarter Date No of Estimates Ebitda Ebit
Low High Average Low High Average
2028-12-31 8 -282.78M -214.41M -251.64M -292.21M -221.56M -260.03M
2028-09-30 6 -226.2M -171.51M -201.29M -233.75M -177.23M -208M
2028-06-30 5 -192.75M -146.15M -171.53M -199.18M -151.02M -177.25M
2028-03-31 5 -148.61M -112.68M -132.25M -153.57M -116.44M -136.66M
2027-12-31 6 -185.75M -140.84M -165.29M -191.94M -145.53M -170.8M
2027-09-30 6 -162.82M -123.45M -144.89M -168.25M -127.57M -149.72M
Quarter Date No of Estimates NetIncome SgaExpense
Low High Average Low High Average
2028-12-31 8 187.41M 269.37M 232.04M 873.24M 1.15B 1.02B
2028-09-30 6 151.75M 218.12M 187.89M 698.51M 921.26M 819.81M
2028-06-30 5 129.58M 186.26M 160.44M 595.22M 785.03M 698.58M
2028-03-31 5 100.08M 143.84M 123.91M 458.92M 605.27M 538.61M
2027-12-31 6 70.71M 101.63M 87.55M 573.59M 756.5M 673.19M
2027-09-30 6 48.39M 69.55M 59.92M 502.78M 663.12M 590.09M
Quarter Date No of Revenue Estimates Revenue No of EPS Estimates EPS
Low High Average Low High Average
2028-12-31 8 595.09M 784.86M 698.43M 5 3.66043 5.26129 4.53217
2028-09-30 6 476.02M 627.82M 558.68M 5 2.96402 4.26031 3.66991
2028-06-30 5 405.63M 534.98M 476.07M 6 2.53101 3.63792 3.13377
2028-03-31 5 312.74M 412.47M 367.05M 3 1.95467 2.80953 2.42018
2027-12-31 6 390.89M 515.54M 458.76M 2 1.38109 1.9851 1.71
2027-09-30 6 342.63M 451.9M 402.13M 2 0.94517 1.35853 1.17026